# Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/comparative-effectiveness-of-remestemcel-l-rknd-versus-ruxolitinib-in-pediatric/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gabriel Tremblay,D. Tomaras,E Strati,Anna Forsythe |
| Citations | 4 |
| DOI | 10.36469/jheor.2021.19008 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jheor.org/article/19008.pdf |
| OpenAlex ID | https://openalex.org/W3133160633 |
| PMID | 33768123 |
| Type | article |
| Year | 2021 |

## Paper authors

- [D. Tomaras](https://scholariq.org/researchers/d-tomaras/)

## Paper journal

- [Journal of health economics and outcomes research](https://scholariq.org/journals/journal-of-health-economics-and-outcomes-research/)

## Paper primary topic

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)

## Paper topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [Neutropenia and Cancer Infections](https://scholariq.org/topics/neutropenia-and-cancer-infections/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.